| Overview |
| bsm-61002r |
| GABARAPL2 Recombinant Antibody |
| WB |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human GABARAPL2 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 11345 |
| P60520 |
| Cytoplasm |
| ATG 8; ATG8; FLC 3A; FLC3A; GABA(A) receptor associated protein like 2; Gamma aminobutyric acid receptor associated protein like 2; Ganglioside expression factor 2; GATE 16; GATE16; General protein transport factor p16; MAP1 light chain 3 related protein; GABA(A) receptor-associated protein-like 2; Gabarapl2; Gamma-aminobutyric acid receptor-associated protein-like 2; GATE-16; GBRL2_HUMAN; GEF 2; GEF-2; GEF2; Golgi-associated ATPase enhancer of 16 kDa; MAP1 light chain 3-related protein. |
| Enables ubiquitin protein ligase binding activity. Involved in negative regulation of proteasomal protein catabolic process and protein localization to endoplasmic reticulum. Located in Golgi membrane and autophagosome membrane. [provided by Alliance of Genome Resources, Apr 2022] |
| Application Dilution |
| WB |
1:300-5000 |